RFA-CA-24-011 - Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) is used for the submission of applications to the following Notices of Special Interest (NOSIs)
Expired NOSIs
| Title | Notice Number | Organization | Release Date | Expiration Date | Activity Code(s) |
|---|---|---|---|---|---|
| Notice of Special Interest (NOSI): Technology Development for Cancer Control and Population Science Research | NOT-CA-23-037 | NCI | Jan 18, 2023 | Dec 31, 2024 | U01, R21, R61, R33, U24 |
| Notice of Special Interest (NOSI): Technologies and Informatics Tools for Cancer Metabolomics | NOT-CA-22-083 | NCI | Apr 26, 2022 | Dec 31, 2024 | R33, R61, R21, U24, U01 |
For technical issues E-mail OER Webmaster